$5.41
20.56% today
Nasdaq, Apr 04, 09:16 pm CET
ISIN
US5147661046
Symbol
LFCR

Landec Corporation Stock price

$6.81
+1.09 19.06% 1M
+2.11 44.74% 6M
-0.62 8.34% YTD
+0.66 10.73% 1Y
-4.80 41.34% 3Y
-2.98 30.44% 5Y
-7.68 53.00% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.39 5.42%
ISIN
US5147661046
Symbol
LFCR

Key metrics

Market capitalization $252.14m
Enterprise Value $418.33m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3.20
P/S ratio (TTM) P/S ratio 1.93
P/B ratio (TTM) P/B ratio 16.30
Revenue growth (TTM) Revenue growth 14.97%
Revenue (TTM) Revenue $130.86m
EBIT (operating result TTM) EBIT $-9.89m
Free Cash Flow (TTM) Free Cash Flow $-14.40m
Cash position $9.46m
EPS (TTM) EPS $-0.58
P/E forward negative
P/S forward 1.96
EV/Sales forward 3.26
Short interest 11.70%
Show more

Is Landec Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Landec Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Landec Corporation forecast:

1x Buy
50%
1x Hold
50%

Analyst Opinions

2 Analysts have issued a Landec Corporation forecast:

Buy
50%
Hold
50%

Financial data from Landec Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Nov '24
+/-
%
131 131
15% 15%
100%
- Direct Costs 85 85
2% 2%
65%
46 46
69% 69%
35%
- Selling and Administrative Expenses 39 39
22% 22%
30%
- Research and Development Expense 8.44 8.44
1% 1%
6%
-2.23 -2.23
84% 84%
-2%
- Depreciation and Amortization 7.66 7.66
12% 12%
6%
EBIT (Operating Income) EBIT -9.89 -9.89
56% 56%
-8%
Net Profit -14 -14
80% 80%
-11%

In millions USD.

Don't miss a Thing! We will send you all news about Landec Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Landec Corporation Stock News

Neutral
Seeking Alpha
about 20 hours ago
Lifecore Biomedical, Inc. (NASDAQ:LFCR ) Q3 2025 Earnings Conference Call April 3, 2025 4:30 PM ET Company Participants Stephanie Diaz - Manager, IR Paul Josephs - CEO Ryan Lake - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Michael Petusky - Barrington Research Operator Good afternoon, and thank you for joining Lifecore's Fiscal 2025 Third Quarter Earnings Call. Du...
Neutral
GlobeNewsWire
about 23 hours ago
-- Recorded Revenues of $35.2 Million for Q3 Fiscal 2025 -- -- Signed Multiple Development Agreements with New and Existing Customers --
Neutral
GlobeNewsWire
8 days ago
CHASKA, Minn., March 27, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the third quarter of fiscal year 2025 on Thursday, April 3, 2025, after market close.
More Landec Corporation News

Company Profile

Landec Corp. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. It operates through the following segments: Curation Foods, Lifecore, and Others. The Curation Foods segment includes activities to market and pack specialty packaged whole and fresh-cut fruit and vegetables. The Lifecore segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans. The Other segment consists of corporate general and administrative expenses, non-Curation Foods and non-Lifecore interest income, and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Santa Clara, CA.

Head office United States
CEO Paul Josephs
Employees 524
Founded 1986
Website www.lifecore.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today